A Multifunctional Nanocarrier Based on Nanogated Mesoporous Silica for Enhanced Tumor-Specific Uptake and Intracellular Delivery

A multifunctional drug delivery system based on MCM‐41‐type mesoporous silica nanoparticles is described that behaves as if nanogates were covalently attached to the outlets of the mesopores through a highly acid‐sensitive benzoic–imine linker. Tumor‐specific uptake and intracellular delivery results from the pH‐dependent progressive hydrolysis of the benzoic–imine linkage that starts at tumor extracellular pH = 6.8 and increases with decreasing pH. The cleavage of the benzoic–imine bond leads to the removal of the polypseudorotaxane caps and subsequent release of the payload drugs at tumor sites. At the same time, the carrier surface becomes positively charged, which further facilitates cellular uptake of the nanocarriers, thus offering a tremendous potential for targeted tumor therapy. A multifunctional drug carrier based on polypseudorotaxane(PEG/CD)‐nanogated mesoporous silica is presented. It combines multifunctionality, i.e., enhanced tumor‐specific cellular uptake, intracellular delivery, biocompatibility, and potential in vivo longevity in one nanoparticle and offers therefore a huge potential in targeting tumor therapy.